When Is Pharmacotherapy Initiation Beneficial in Patients With Depressive Disorders?

Drew Prescott, Nicole D. White

Research output: Contribution to journalArticle

Abstract

Psychotherapy and pharmacotherapy are the most common treatments utilized in patients diagnosed with depressive disorders. Their efficacy in remitting symptoms and restoring patients to baseline functioning has been established throughout the literature; however, questions still remain on whether pharmacotherapy is necessary in all patients and if used, when initiation is most beneficial. Current guidelines recommend initiating only psychotherapy in patients with mild depression and advancing to pharmacotherapy as appropriate. Evidence-based literature has shown pharmacotherapy to have a significant and independent treatment effect in depressive disorders compared with psychotherapy. Combination treatment with both modalities has also shown to be beneficial for remitting depressive symptoms in this patient population. Therefore, treatment should be individualized for each specific patient based on severity of disease, history of depression and response to treatment, cost of treatment, and patient preference.

Original languageEnglish (US)
Pages (from-to)220-222
Number of pages3
JournalAmerican Journal of Lifestyle Medicine
Volume11
Issue number3
DOIs
StatePublished - 2017

Fingerprint

Depressive Disorder
Drug Therapy
Psychotherapy
Depression
Therapeutics
Patient Preference
Health Care Costs
Guidelines
Population

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

When Is Pharmacotherapy Initiation Beneficial in Patients With Depressive Disorders? / Prescott, Drew; White, Nicole D.

In: American Journal of Lifestyle Medicine, Vol. 11, No. 3, 2017, p. 220-222.

Research output: Contribution to journalArticle

@article{191976931ade42cc864a1f313d1c8f71,
title = "When Is Pharmacotherapy Initiation Beneficial in Patients With Depressive Disorders?",
abstract = "Psychotherapy and pharmacotherapy are the most common treatments utilized in patients diagnosed with depressive disorders. Their efficacy in remitting symptoms and restoring patients to baseline functioning has been established throughout the literature; however, questions still remain on whether pharmacotherapy is necessary in all patients and if used, when initiation is most beneficial. Current guidelines recommend initiating only psychotherapy in patients with mild depression and advancing to pharmacotherapy as appropriate. Evidence-based literature has shown pharmacotherapy to have a significant and independent treatment effect in depressive disorders compared with psychotherapy. Combination treatment with both modalities has also shown to be beneficial for remitting depressive symptoms in this patient population. Therefore, treatment should be individualized for each specific patient based on severity of disease, history of depression and response to treatment, cost of treatment, and patient preference.",
author = "Drew Prescott and White, {Nicole D.}",
year = "2017",
doi = "10.1177/1559827616686051",
language = "English (US)",
volume = "11",
pages = "220--222",
journal = "American Journal of Lifestyle Medicine",
issn = "1559-8276",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - When Is Pharmacotherapy Initiation Beneficial in Patients With Depressive Disorders?

AU - Prescott, Drew

AU - White, Nicole D.

PY - 2017

Y1 - 2017

N2 - Psychotherapy and pharmacotherapy are the most common treatments utilized in patients diagnosed with depressive disorders. Their efficacy in remitting symptoms and restoring patients to baseline functioning has been established throughout the literature; however, questions still remain on whether pharmacotherapy is necessary in all patients and if used, when initiation is most beneficial. Current guidelines recommend initiating only psychotherapy in patients with mild depression and advancing to pharmacotherapy as appropriate. Evidence-based literature has shown pharmacotherapy to have a significant and independent treatment effect in depressive disorders compared with psychotherapy. Combination treatment with both modalities has also shown to be beneficial for remitting depressive symptoms in this patient population. Therefore, treatment should be individualized for each specific patient based on severity of disease, history of depression and response to treatment, cost of treatment, and patient preference.

AB - Psychotherapy and pharmacotherapy are the most common treatments utilized in patients diagnosed with depressive disorders. Their efficacy in remitting symptoms and restoring patients to baseline functioning has been established throughout the literature; however, questions still remain on whether pharmacotherapy is necessary in all patients and if used, when initiation is most beneficial. Current guidelines recommend initiating only psychotherapy in patients with mild depression and advancing to pharmacotherapy as appropriate. Evidence-based literature has shown pharmacotherapy to have a significant and independent treatment effect in depressive disorders compared with psychotherapy. Combination treatment with both modalities has also shown to be beneficial for remitting depressive symptoms in this patient population. Therefore, treatment should be individualized for each specific patient based on severity of disease, history of depression and response to treatment, cost of treatment, and patient preference.

UR - http://www.scopus.com/inward/record.url?scp=85019192770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019192770&partnerID=8YFLogxK

U2 - 10.1177/1559827616686051

DO - 10.1177/1559827616686051

M3 - Article

VL - 11

SP - 220

EP - 222

JO - American Journal of Lifestyle Medicine

JF - American Journal of Lifestyle Medicine

SN - 1559-8276

IS - 3

ER -